<DOC>
	<DOCNO>NCT02734732</DOCNO>
	<brief_summary>This study examine single dose Ciprofloxacin Trimethoprim/Sulfamethoxazole equivalent prophylaxis immediately prior prostate biopsy , patient suspect prostate cancer .</brief_summary>
	<brief_title>Antibiotic Prophylaxis Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole</brief_title>
	<detailed_description>Background : The number prostate biopsy estimate approximately 1.000.000 year I Europe1 . The infection rate transrectal prostate biopsy increase annually2 . The common antibiotic use prophylaxis Ciprofloxacin , however , Trimethoprim/Sulfamethoxazole also feasible alternative3 . Aim : To evaluate best antibiotic prophylaxis prior trans rectal prostate biopsy low risk patient . Outcome : Hospitalization infection within 14 day biopsy . Method : By randomization eligible patient low risk infectious complication . Patient treat physician blind treatment allocation . By use nationwide full coverage national patient register ( NPR ) , mandatory inpatient care4 . All patient identify Swedish personal identification number5 . Both patient relate baseline characteristic gather register linkage . To validate outcome variable , patient admit hospital within 14 day subject chart review . Comparing patient participate unit , code specific trans rectal biopsy , compare exclude patient well included patient , make separate exclusion analysis . The standard operate procedure randomization patient fill form inform consent participation prior plan biopsy . If exclusion criterion fill informed consent obtain , patient randomize web base randomization program , date biopsy , early prostate biopsy , number biopsy , PSA prostate size collect . Other baseline variable obtain cross linkage NPR National Prostate Cancer Registry . A randomization number give patient stage key code establish participate unit contain every patient randomization number subsequent personal identification number . After complete requirement , data collect Västernorrlands Läns Landsting analyze accord protocol . Analysis make logistic regression point estimate Single side 97.5 % Confidence Interval . Sample size calculate require 2800 patient assume 0.5 % frequency infection , able detect difference 0.75 % absolute proportion infection . Missing data outcome variable , receive treatment date biopsy exclude analysis .</detailed_description>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>Indication trans rectal prostate biopsy ( Physicians discretion ) Informed consent Diabetes Mellitus Indwelling urinary catheter Prior urinary infection ( last 6 month ) Dipstick positive ( Nitrites test ) Allergy Ciprofloxacin Trimethoprim/Sulfamethoxazole Severe liver disease Concomittant use Tizanidine Immunosuppression</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Infection</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Antibiotic</keyword>
</DOC>